Design of ultrasonically-activatable nanoparticles using low boiling point perfluorocarbons

Biomaterials

Volumn 33, Issue 11, 2012, Pages 3262-3269

  Sheeran, Paul S ^a   Luois, Samantha H ^b   Mullin, Lee B ^a   Matsunaga, Terry O ^b   Dayton, Paul A ^a  

^a USA and North Carolina State University   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Acoustically responsive material; Fluorocarbon; Nanoparticle; Phospholipid; Thermally responsive material; Ultrasound

Indexed keywords

ACOUSTIC ACTIVITY; ACOUSTIC ENERGY; ACOUSTIC PARAMETERS; CONTRAST AGENT; CRUCIAL PARAMETERS; CUSTOM DESIGN; EMULSION STABILITY; GASEOUS STATE; IN-VIVO; MEDICAL ULTRASONICS; MICROBUBBLES; PERFLUOROCARBONS; PHASE CHANGES; THERMALLY RESPONSIVE MATERIAL;

BIOLOGICAL MATERIALS; BOILING POINT; EMULSIFICATION; FLUOROCARBONS; NANOPARTICLES; PHOSPHOLIPIDS; SIZE DISTRIBUTION;

ULTRASONICS;

FLUOROCARBON; LOW BOILING POINT PERFLUOROCARBON; NANOPARTICLE; PERFLUTREN; PHASE CHANGE CONTRAST AGENT; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; EMULSION; ENVIRONMENTAL TEMPERATURE; GAS MIXING; PARTICLE SIZE; PHYSICAL SENSITIVITY; PRIORITY JOURNAL; SYNTHESIS; THERMOSTABILITY; ULTRASOUND;

CONTRAST MEDIA; FLUOROCARBONS; GASES; MATERIALS TESTING; NANOPARTICLES; PHASE TRANSITION; SONICATION; TRANSITION TEMPERATURE; ULTRASONOGRAPHY;

EID: 84856576887     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.01.021     Document Type: Article

References (46)

1. Kim T., Huh Y.M., Haam S., Lee K. Activatable nanomaterials at the forefront of biomedical sciences. JMater Chem 2010, 20(38):8194-8206.
2. Kripfgans O.D., Fowlkes J.B., Miller D.L., Eldevik O.P., Carson P.L. Acoustic droplet vaporization for therapeutic and diagnostic applications. Ultrasound Med Biol 2000, 26(7):1177-1189.
3. Kripfgans O.D., Fowlkes J.B., Woydt M., Eldevik O.P., Carson P.L. Invivo droplet vaporization for occlusion therapy and phase aberration correction. IEEE Trans Ultrason Ferroelectr Freq Control 2002, 49(6):726-738.
4. Fabiilli M.L., Lee J.A., Kripfgans O.D., Carson P.L., Fowlkes J.B. Delivery of water-soluble drugs using acoustically triggered perfluorocarbon double emulsions. Pharm Res 2010, 27(12):2753-2765.
5. Miller D.L., Kripfgans O.D., Fowlkes J.B., Carson P.L. Cavitation nucleation agents for nonthermal ultrasound therapy. JAcoust Soc Am 2000, 107(6):3480-3486.
6. Zhang M., Fabiilli M.L., Haworth K.J., Padilla F., Swanson S.D., Kripfgans O.D., et al. Acoustic droplet vaporization for enhancement of thermal ablation by high intensity focused ultrasound. Acad Radiol 2011, 18(9):1123-1132.
7. Campbell R.B. Tumor physiology and delivery of nanopharmaceuticals. Anticancer Agents Med Chem 2006, 6(6):503-512.
8. Rapoport N.Y., Kennedy A.M., Shea J.E., Scaife C.L., Nam K.H. Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. JControl Release 2009, 138(3):268-276.
9. Zhang P., Porter T. An invitro study of a phase-shift nanoemulsion: a potential nucleation agent for bubble-enhanced HIFU tumor ablation. Ultrasound Med Biol 2010, 36(11):1856-1866.
10. Wang C.H., Kang S.T., Lee Y.H., Luo Y.L., Huang Y.F., Yeh C.K. Aptamer-conjugated and drug-loaded acoustic droplets for ultrasound theranosis. Biomaterials 2012, 33(6):1939-1947.
11. Lantheus Medical Imaging. Definity® (perflutren lipid microsphere) injectable suspension. N Billerica, MA: Lantheus Medical Imaging. Online. 2011. Available from: URL: http://www.definityimaging.com/main.html.
12. Porter TR. Ultrasound contrast agents and methods for their manufacture and use. US Patent No. 5567415, 1996.
13. Mullin L., Gessner R., Kwan J., Kaya M., Borden M.A., Dayton P.A. Effect of anesthesia carrier gas on invivo circulation times of ultrasound microbubble contrast agents in rats. Contrast Media Mol Imaging 2011, 6(3):126-131.
14. Wei K., Mulvagh S.L., Carson L., Davidoff R., Gabriel R., Grimm R.A., et al. The safety of definity and optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses. JAm Soc Echocardiogr 2008, 21(11):1202-1206.
15. Porter T.R., Xie F. Transient myocardial contrast after initial exposure to diagnostic ultrasound pressures with minute doses of intravenously injected microbubbles: demonstration and potential mechanisms. Circulation 1995, 92(9):2391-2395.
16. Wei K., Jayaweera A.R., Firoozan S., Linka A., Skyba D.M., Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998, 97(5):473-483.
17. Klibanov A.L. Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications. Invest Radiol 2006, 41(3):354-362.
18. Gessner R., Dayton P.A. Advances in molecular imaging with ultrasound. Mol Imaging 2010, 9(3):117-127.
19. Chomas J.E., Pollard R.E., Sadlowski A.R., Griffey S.M., Wisner E.R., Ferrara K.W. Contrast-enhanced US of microcirculation of superficially implanted tumors in rats. Radiology 2003, 229(2):439-446.
20. Ferrara K., Pollard R., Borden M. Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. Annu Rev Biomed Eng 2007, 9:415-447.
21. Tachibana K., Tachibana S. Albumin microbubble echo-contrast material as an enhancer for ultrasound accelerated thrombolysis. Circulation 1995, 92(5):1148-1150.
22. Tran B.C., Seo J., Hall T.L., Fowlkes J.B., Cain C.A. Microbubble-enhanced cavitation for noninvasive ultrasound surgery. IEEE Trans Ultrason Ferroelectr Freq Control 2003, 50(10):1296-1304.
23. Stride E.P., Coussios C.C. Cavitation and contrast: the use of bubbles in ultrasound imaging and therapy. Proc Inst Mech Eng H 2010, 224(H2):171-191.
24. Hall C.S., Lanza G.M., Rose J.H., Kaufmann R.J., Fuhrhop R.W., Handley S.H., et al. Experimental determination of phase velocity of perfluorocarbons: applications to targeted contrast agents. IEEE Trans Ultrason Ferroelectr Freq Control 2000, 47(1):75-84.
25. Pisani E., Tsapis N., Paris J., Nicolas V., Cattel L., Fattal E. Polymeric nano/microcapsules of liquid perfluorocarbons for ultrasonic imaging: physical characterization. Langmuir 2006, 22(9):4397-4402.
26. Mattrey R.F. Perfluorooctylbromide: a new contrast agent for CT, sonography, and MR imaging. AJR Am J Roentgenol 1989, 152(2):247-252.
27. Quay SC. Phase shift colloids as ultrasound contrast agents. US Patent No. 5558853, 1996.
28. Apfel RE. Activatable infusable dispersions containing drops of a superheated liquid for methods of therapy and diagnosis. US Patent No. 5840276, 1998.
29. Rapoport N., Nam K.H., Gupta R., Gao Z., Mohan P., Payne A., et al. Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions. JControl Release 2011, 153(1):4-15.
30. Couture O., Faivre M., Pannacci N., Babataheri A., Servois V., Tabeling P., et al. Ultrasound internal tattooing. Med Phys 2011, 38(2):1116-1123.
31. Strohm E., Rui M., Gorelikov I., Matsuura N., Kolios M. Vaporization of perfluorocarbon droplets using optical irradiation. Biomed Opt Express 2011, 2:1432-1442.
32. Rajian J.R., Fabiilli M.L., Fowlkes J.B., Carson P.L., Wang X. Drug delivery monitoring by photoacoustic tomography with an ICG encapsulated double emulsion. Opt Express 2011, 19(15):14335-14347.
33. Sheeran P.S., Wong V.P., Luois S., McFarland R.J., Ross W.D., Feingold S., et al. Decafluorobutane as a phase-change contrast agent for low-energy extravascular ultrasonic imaging. Ultrasound Med Biol 2011, 37(9):1518-1530.
34. Sheeran P.S., Luois S., Dayton P.A., Matsunaga T.O. Formulation and acoustic studies of a new phase-shift agent for diagnostic and therapeutic ultrasound. Langmuir 2011, 27(17):10412-10420.
35. Kawabata K.I., Sugita N., Yoshikawa H., Azuma T., Umemura S.I. Nanoparticles with multiple perfluorocarbons for controllable ultrasonically induced phase shifting. Jpn J Appl Phys 2005, 44(6B):4548-4552.
36. Hernot S., Klibanov A.L. Microbubbles in ultrasound-triggered drug and gene delivery. Adv Drug Deliv Rev 2008, 60(10):1153-1166.
37. Schad K.C., Hynynen K. Invitro characterization of perfluorocarbon droplets for focused ultrasound therapy. Phys Med Biol 2010, 55(17):4933-4947.
38. Qin S., Kruse D.E., Ferrara K.W. Transmitted ultrasound pressure variation in micro blood vessel phantoms. Ultrasound Med Biol 2008, 34(6):1014-1020.
39. Evans D.R., Parsons D.F., Craig V.S.J. Physical properties of phase-change emulsions. Langmuir 2006, 22(23):9538-9545.
40. Giesecke T., Hynynen K. Ultrasound-mediated cavitation thresholds of liquid perfluorocarbon droplets invitro. Ultrasound Med Biol 2003, 29(9):1359-1365.
41. Huh D., Bahng J.H., Ling Y., Wei H.H., Kripfgans O.D., Fowlkes J.B., et al. Gravity-driven microfluidic particle sorting device with hydrodynamic separation amplification. Anal Chem 2007, 79(4):1369-1376.
42. Nieuwstadt H.A., Seda R., Li D.S., Fowlkes J.B., Bull J.L. Microfluidic particle sorting utilizing inertial lift force. Biomed Microdevices 2010, 13(1):97-105.
43. Bardin D., Martz T.D., Sheeran P.S., Shih R., Dayton P.A., Lee A.P. High-speed, clinical-scale microfluidic generation of stable phase-change droplets for gas embolotherapy. Lab Chip 2011, 11:3990-3998.
44. Martz T.D., Sheeran P.S., Bardin D., Lee A.P., Dayton P.A. Precision manufacture of phase-change perfluorocarbon droplets using microfluidics. Ultrasound Med Biol 2011, 37(11):1952-1957.
45. Feshitan J.A., Chen C.C., Kwan J.J., Borden M.A. Microbubble size isolation by differential centrifugation. JColloid Interface Sci 2009, 329(2):316-324.
46. Talu E., Hettiarachchi K., Zhao S., Powell R.L., Lee A.P., Longo M.L., et al. Tailoring the size distribution of ultrasound contrast agents: possible method for improving sensitivity in molecular imaging. Mol Imaging 2007, 6(6):384-392.